Cargando…

An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells

Chromatin regulators control cellular differentiation by orchestrating dynamic developmental gene expression programs, and hence, malfunctions in the regulation of chromatin state contribute to both developmental disorders and disease state. Mll4 (Kmt2d), a member of the COMPASS (COMplex of Proteins...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Kaixiang, Collings, Clayton K., Morgan, Marc A., Marshall, Stacy A., Rendleman, Emily J., Ozark, Patrick A., Smith, Edwin R., Shilatifard, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796793/ https://www.ncbi.nlm.nih.gov/pubmed/29404406 http://dx.doi.org/10.1126/sciadv.aap8747

Ejemplares similares

Histone H3K4 methylation-dependent and -independent functions of Set1A/COMPASS in embryonic stem cell self-renewal and differentiation
por: Sze, Christie C., et al.
Publicado: (2017)

SET1A/COMPASS and shadow enhancers in the regulation of homeotic gene expression
por: Cao, Kaixiang, et al.
Publicado: (2017)

A small UTX stabilization domain of Trr is conserved within mammalian MLL3-4/COMPASS and is sufficient to rescue loss of viability in null animals
por: Rickels, Ryan, et al.
Publicado: (2020)

The Mll2 branch of the COMPASS family regulates bivalent promoters in mouse embryonic stem cells
por: Hu, Deqing, et al.
Publicado: (2013)

Coordinated regulation of cellular identity–associated H3K4me3 breadth by the COMPASS family
por: Sze, Christie C., et al.
Publicado: (2020)

CARM1-mediated methylation of ASXL2 impairs tumor-suppressive function of MLL3/COMPASS
por: Zhao, Zibo, et al.
Publicado: (2022)

Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations
por: Zhao, Zibo, et al.
Publicado: (2023)

Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia
por: Zhao, Zibo, et al.
Publicado: (2019)

A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation
por: Morgan, Marc A.J., et al.
Publicado: (2017)

A synthetic lethality screen reveals ING5 as a genetic dependency of catalytically dead Set1A/COMPASS in mouse embryonic stem cells
por: Cenik, Bercin K., et al.
Publicado: (2022)

A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism
por: Wang, Lu, et al.
Publicado: (2017)

Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
por: Feng, Zizhen, et al.
Publicado: (2016)

TET2 coactivates gene expression through demethylation of enhancers
por: Wang, Lu, et al.
Publicado: (2018)

Conservation of epigenetic regulation by the MLL3/4 tumour suppressor in planarian pluripotent stem cells
por: Mihaylova, Yuliana, et al.
Publicado: (2018)

Impact of human MLL/COMPASS and polycomb complexes on the DNA methylome
por: Putiri, Emily L., et al.
Publicado: (2014)

Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis
por: Ballabio, Erica, et al.
Publicado: (2012)

Epigenetic control of gene expression in leukemogenesis: Cooperation between wild type MLL and MLL fusion proteins
por: Ballabio, Erica, et al.
Publicado: (2014)

Pre-clinical activity of combined LSD1 and mTORC1 inhibition in MLL-translocated acute myeloid leukaemia
por: Deb, Gauri, et al.
Publicado: (2019)

Set1/COMPASS and Mediator are repurposed to promote epigenetic transcriptional memory
por: D'Urso, Agustina, et al.
Publicado: (2016)

Zic2 is an enhancer-binding factor required for embryonic stem cell specification
por: Luo, Zhuojuan, et al.
Publicado: (2015)

Epigenetic regulation of LSD1 during mammary carcinogenesis
por: Wu, Yadi, et al.
Publicado: (2014)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
por: Chan, Anthony K. N., et al.
Publicado: (2019)

Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells
por: Liu, Y, et al.
Publicado: (2014)

β-Catenin/Tcf7l2–dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer
por: Zhao, Zibo, et al.
Publicado: (2019)

Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma
por: Patel, Priyal O., et al.
Publicado: (2019)

MLL1/WDR5 complex in leukemogenesis and epigenetic regulation
por: Wu, Min, et al.
Publicado: (2011)

MLL1 promotes myogenesis by epigenetically regulating Myf5
por: Cai, Shufang, et al.
Publicado: (2019)

Landscape inferred from gene expression data governs pluripotency in embryonic stem cells
por: Kang, Xin, et al.
Publicado: (2020)

Epigenetic Regulation of Cardiomyocyte Differentiation from Embryonic and Induced Pluripotent Stem Cells
por: Kim, Yong-Jin, et al.
Publicado: (2021)

Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis
por: Alsaqer, Saqer F., et al.
Publicado: (2017)

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia
por: Tirtakusuma, Ricky, et al.
Publicado: (2022)

Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
por: Muñoz-López, Alvaro, et al.
Publicado: (2016)

MLL1 Inhibition and Vitamin D Signaling Cooperate to Facilitate the Expanded Pluripotency State
por: Zhang, Hui, et al.
Publicado: (2019)

Metabolic–Epigenetic Axis in Pluripotent State Transitions
por: D’Aniello, Cristina, et al.
Publicado: (2019)

Epigenetics of Pluripotent Cells
por: Medvedev, S.P., et al.
Publicado: (2012)

Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between AF4-MLL and MLL-AF4 fusions
por: Bueno, Clara, et al.
Publicado: (2019)

Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition
por: Zeng, Cheng, et al.
Publicado: (2023)

Structural implications of Dpy30 oligomerization for MLL/SET1 COMPASS H3K4 trimethylation
por: Zhang, Hongmei, et al.
Publicado: (2014)

The birth of embryonic pluripotency
por: Boroviak, Thorsten, et al.
Publicado: (2014)

LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer
por: Ding, J, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rhrs3j1kfbckn8v117ol8fhnnm